bmiMD review

The costs at a glance

A clear choice between monthly payment and prepayment

bmiMD lists compounded semaglutide at $159 for one month, $447 for three months, $774 for six months and $1, 428 for twelve months. Those longer totals correspond to advertised equivalents of $149, $129 and $119 monthly. I appreciate seeing the cash commitment beside the average because it makes the choice more concrete. The annual rate is not an installment of $119 unless the selected checkout separately says so. Start with the amount actually charged and the number of months it buys. Then compare the discount with the flexibility you give up when paying for future treatment before knowing how the clinical plan develops. Read our prepaid-plan calculator for the next questions to work through.

The advertised package includes medical access

The product page describes a telehealth visit, prescription fulfillment when appropriate, messaging with the medical provider and delivery. The homepage also lists medication supplies and ongoing order support. I would confirm that every required item for the selected prescription is part of that total and ask whether any testing sits outside it. A package is easier to evaluate when clinical questions go to the prescriber and delivery questions go to the support team. Keep those contact routes available after the first order. Included access is useful, but its practical value depends on how quickly a relevant clinician can respond when the treatment needs review.

A longer plan continues after renewal is switched off

The refund policy describes longer plans as prepaid subscriptions that ship in installments. Cancelling turns off the next renewal; it does not automatically unwind the current term. Voluntary cancellation after the initial order reaches the pharmacy generally leaves the payment non-refundable, with remaining shipment or credit options described. I would read this alongside the annual savings before selecting a term. A smaller average can be outweighed by an unused commitment if your needs change. Ask for the exact shipment schedule and what happens to the balance if you stop treatment, rather than assume that unshipped installments mean a cash refund.

Watch the renewal cutoff before the authorization hold

bmiMD’s policy requires cancellation by 11:59 p.m. Eastern at least seven days before renewal, and describes an authorization hold five days before renewal. That means the cancellation deadline comes before the hold. I would set a reminder from the account’s actual renewal date and retain the confirmation of any pause or cancellation. Do not wait for a bank notification to decide whether another term is wanted. The policy allows account-based management or email, which gives a record of the request. Verify the upcoming amount too: an initial discount and an ongoing renewal price should not be assumed identical without the checkout’s confirmation. Read our cancellation guide for the next questions to work through.

Ineligibility and a change of mind have different rules

The policy distinguishes a clinician declining treatment from a customer asking to cancel after submitting intake. It describes releasing the authorization if treatment is not approved, but a $100 intake processing fee for customer-requested cancellation after submission. I would not summarize both situations as a risk-free purchase. If you are still deciding between providers, finish that comparison before authorizing an intake. Ask what stage the order has reached before expecting a refund. A clinical decision that a treatment is unsuitable and a voluntary withdrawal are different events under these terms, and the amount retained can differ accordingly.

Compounding claims are not FDA approval

bmiMD describes pharmacy testing and licensed U. S.compounding partners. These are purchasing details to investigate, but they do not make the finished compounded prescription FDA-approved. FDA says compounded GLP-1 products do not receive its premarket review for safety, effectiveness or quality. I would ask for the assigned pharmacy and the exact formulation, then confirm any unclear label or administration instructions with the pharmacist. A quality-testing description is not an individual patient’s guarantee. Keep clinical suitability separate from the attractive price ladder: a lower payment is not a reason to treat different products or formulations as interchangeable. Read our pharmacy verification guide for the next questions to work through.

Nationwide access still needs a prescription-specific answer

The semaglutide page advertises all-fifty-state telehealth and delivery. The service process still involves a clinician deciding whether the treatment is appropriate. I would check the proposed medication, physical location for the visit and actual pharmacy fulfillment before planning around that broad access claim. The homepage gives a usual delivery estimate after approval rather than a guaranteed arrival date. If switching providers, clarify the review and shipment sequence so you are not relying on a marketing estimate for continuity. Existing records can help the conversation, but a previous prescription does not bind a new provider to the same plan.

My assessment: unusually usable totals, meaningful exit risk

The strongest feature of bmiMD’s presentation is its explicit short-plan price and prepaid totals. That gives readers something concrete to compare without inventing the first charge. My reservation is the commitment: the savings become less persuasive when someone is uncertain about staying with a service or tolerating a prescribed treatment. I would use the monthly option as the baseline and treat a longer term as a separate financial decision. Compare Amble for another term-based arrangement or DirectMeds for a different direct-pay offer, while matching the actual prescription and included care. The clearest number is useful only when the surrounding obligation is equally clear.

Before you sign up

• What date is the seven-day renewal cutoff?
• What happens to prepaid shipments if treatment stops?
• Which pharmacy and supply schedule apply?

Use the answers to compare the exact offer with another provider. A service review cannot determine whether a medication is appropriate for you; that decision belongs with your clinician.